-+ 0.00%
-+ 0.00%
-+ 0.00%

Adeia (ADEA) On RPX Licensing Deal And The Undervalued Narrative

Simply Wall St·07/11/2026 17:25:16
語音播報

Adeia stock reacts to new RPX licensing deal

Adeia (ADEA) drew fresh attention after announcing a multiyear license agreement with RPX Corporation, giving 10 RPX member companies access to Adeia's media intellectual property across search, content discovery and digital commerce technologies.

See our latest analysis for Adeia.

At a share price of $28.98, Adeia has eased in the short term, with the 30 day share price return down 6.06%. Momentum over longer horizons remains strong, highlighted by a year to date share price return of 64.85% and a very large 5 year total shareholder return of 498.03%. The latest RPX deal adds another reference point for how the market is weighing future licensing potential and risk.

If Adeia's licensing progress has your attention, this could be a good moment to broaden your research and scan the market using our 18 top founder-led companies

Adeia appears to be a solid IP licensing platform with a fresh RPX deal in hand and a share price that has already moved sharply over the past year. The key question is whether the current valuation still offers enough potential return to justify the risk.

Most Popular Narrative: 21.7% Undervalued

At a last close of $28.98 versus a narrative fair value of $37.00 using an 8.87% discount rate, Adeia is framed as undervalued in the most followed storyline, with licensing wins and patent monetization doing much of the heavy lifting in that view.

Adeia's disciplined capital allocation, strong cash generation, and continued investment in expanding its patent portfolio (up 6% year-to-date) support ongoing innovation, sustain high-margin recurring licensing, and maintain financial flexibility for debt reduction and shareholder returns, all of which enhance long-term value creation and potential upside to net margins and earnings.

Read the complete narrative.

Curious what kind of revenue path and margin profile support that fair value gap for Adeia? The narrative leans on shrinking top line, lower profitability, and a much richer future earnings multiple to make the numbers work.

Result: Fair Value of $37 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this Adeia narrative could be knocked off course if regulatory changes weaken IP enforcement, or if major licensing renewals and settlements arrive slower than expected.

Find out about the key risks to this Adeia narrative.

Another View on Adeia valuation

The first narrative framed Adeia as 21.7% undervalued relative to a $37.00 fair value, yet the SWS DCF model points the other way, with a future cash flow value of $23.10 versus the current $28.98 share price. This implies the stock screens as expensive on this lens. That kind of split naturally raises the question of which set of assumptions you find more realistic.

Look into how the SWS DCF model arrives at its fair value.

ADEA Discounted Cash Flow as at Jul 2026
ADEA Discounted Cash Flow as at Jul 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Adeia for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the split views on Adeia's valuation leave you undecided, take a closer look at the trade off between concern and optimism, then weigh the 3 key rewards and 3 important warning signs

Looking for more investment ideas beyond Adeia?

If Adeia has sharpened your focus on valuation and risk, do not stop here. Broaden your watchlist with other stocks that match your approach.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.